- Xeris Pharmaceuticals (NASDAQ:XERS) is scheduled to announce Q1 earnings results on Tuesday, May 9th, before market open.
- The consensus EPS Estimate is -$0.15 (+40.0% Y/Y) and the consensus Revenue Estimate is $30.77M (+40.4% Y/Y).
- Over the last 2 years, XERS has beaten EPS estimates 38% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 2 downward. Revenue estimates have seen 0 upward revisions and 2 downward.
Xeris Pharmaceuticals Q1 2023 Earnings Preview
Recommended For You
More Trending News
About XERS Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| XERS | - | - |
| Xeris Biopharma Holdings, Inc. | ||